SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

“If I could, I’d recruit everyone abroad”: Israeli tech feels currency squeeze

Israeli drone defense startup D-Fend explores sale at $1 billion valuation

Full list of Israeli startup M&As in 2026

India’s KPIT to acquire ex–Shin Bet chief Yuval Diskin’s Cymotive for up to $120 million

Buzz

Most popular

Daily

Weekly

1

Kela raising $200 million at $1 billion valuation with backing from Bill Ackman and Eric Schmidt

2

From defense giants to startups: Israel reconsiders how it buys weapons

3

Five bidders advance in Nice’s $2.5 billion Actimize sale process

4

Cisco acquires AI security startup Astrix for $400 million

5

ZyG raises $60 million Series A at $500 million valuation just a year after launch

89Bio

3 stories about 89Bio

Roche strikes $3.5 billion deal for U.S.-Israeli biotech 89bio

Founded in 2018 from Teva’s pipeline, the biotech firm is set to become a centerpiece in Roche’s obesity strategy.

Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO

Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018

מייקל היידן מחקר ו פיתוח טבע

Former Teva Executives Raise $60 Million for Metabolic Disorders Venture

28.10.18|Lilach Baumer

The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva